Cyclacel Pharmaceuticals to Participate in the 2023 BIO CEO
BERKELEY HEIGHTS, N.J., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP;
Globe Newswire30-01-2023, 21:17
Motive is reborn following carve-out of Nokia’s device and service management businesses 8-04-2024, 14:15